Related Experiment Video
Updated: Jan 24, 2026

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
The role of ubiquitin-specific peptidases in cancer progression
Ming-Jer Young1, Kai-Cheng Hsu2,3,4, Tony Eight Lin3
1Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, 701, Taiwan.
Abstract:
Protein ubiquitination is an important mechanism for regulating the activity and levels of proteins under physiological conditions. Loss of regulation by protein ubiquitination leads to various diseases, such as cancer. Two types of enzymes, namely, E1/E2/E3 ligases and deubiquitinases, are responsible for controlling protein ubiquitination. The ubiquitin-specific peptidases (USPs) are the main members of the deubiquitinase family. Many studies have addressed the roles of USPs in various diseases. An increasing number of studies have indicated that USPs are critical for cancer progression, and some USPs have been used as targets to develop inhibitors for cancer prevention. Herein we collect and organize most of the recent studies on the roles of USPs in cancer progression and discuss the development of USP inhibitors for cancer therapy in the future.
Insights
Dysregulation of protein ubiquitination contributes to cancer. This review summarizes recent findings on ubiquitin-specific proteases (USPs) in cancer progression and explores their potential as therapeutic targets for developing novel cancer treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein ubiquitination is a key regulatory process for protein homeostasis.
- Aberrant ubiquitination is implicated in the pathogenesis of various diseases, including cancer.
- Deubiquitinases, particularly ubiquitin-specific proteases (USPs), play crucial roles in reversing ubiquitination.
Purpose of the Study:
- To review the recent literature on the involvement of USPs in cancer progression.
- To consolidate current understanding of USP functions in various cancers.
- To discuss the therapeutic potential of targeting USPs for cancer treatment.
Main Methods:
- Literature review of recent studies on USPs and cancer.
- Analysis of the roles of specific USPs in cancer development and progression.
- Exploration of USP inhibitors as a therapeutic strategy.
Main Results:
- USPs are frequently dysregulated in cancer and significantly impact cancer progression.
- Specific USPs have been identified as oncogenes or tumor suppressors.
- Emerging evidence supports the development of USP inhibitors for cancer therapy.
Conclusions:
- USPs are critical regulators in cancer biology.
- Targeting USPs offers a promising avenue for novel cancer therapies.
- Further research into USP inhibitors is warranted for clinical application.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Dipeptidyl Peptidase 4 Inhibitors
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture

